Advanced search
Publication Cover
Hematology Volume 12, 2007 - Issue 2
Submit an article Journal homepage
219
Views
12
CrossRef citations to date
0
Altmetric
Lymphoproliferative Disease

Gemcitabine, cisplatin and methylprednisolone (GEM-P) with or without Rituximab in relapsed and refractory patients with diffuse large B cell lymphoma (DLBCL)

Bhawna SirohiLymphoma Unit Royal Marsden NHS Foundation Trust, Sutton, Surrey SM2 5PT, UK; Royal Marsden Hospital, Sutton, Surrey SM2 5PT, UK
,
David CunninghamLymphoma UnitRoyal Marsden NHS Foundation Trust, Sutton, Surrey SM2 5PT, UK
,
Andy NormanLymphoma UnitRoyal Marsden NHS Foundation Trust, Sutton, Surrey SM2 5PT, UK; Clinical Trials & Statistics Unit, Institute of Cancer Research, Sutton, Surrey SM2 5PT, UK
,
Kim LastLymphoma UnitRoyal Marsden NHS Foundation Trust, Sutton, Surrey SM2 5PT, UK
,
Ian ChauLymphoma UnitRoyal Marsden NHS Foundation Trust, Sutton, Surrey SM2 5PT, UK
,
Alan HorwichLymphoma UnitRoyal Marsden NHS Foundation Trust, Sutton, Surrey SM2 5PT, UK
,
Jacqui OatesLymphoma UnitRoyal Marsden NHS Foundation Trust, Sutton, Surrey SM2 5PT, UK
,
Geoffrey ChongLymphoma UnitRoyal Marsden NHS Foundation Trust, Sutton, Surrey SM2 5PT, UK
&
Andrew WotherspoonLymphoma UnitRoyal Marsden NHS Foundation Trust, Sutton, Surrey SM2 5PT, UK
 show all
Pages 149-153 | Published online: 04 Sep 2013

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Tara Baetz, Bingshu E. Chen, Stephen Couban, C. Tom Kouroukis, Rena Buckstein, John Kuruvilla, Kang Howson-Jan, David Szwajcer, Massimo Federico, Ralph M. Meyer, Marina S. Djurfeldt, Annette E. Hay, Lois Shepherd & Michael Crump. (2017) Effect of the addition of rituximab to salvage chemotherapy prior to autologous stem cell transplant in aggressive CD20+ lymphoma: a cohort comparison from the NCIC Clinical Trials Group Study LY.12. Leukemia & Lymphoma 58:1, pages 64-69.
Read now
Kazuhito Suzuki, Yasuhito Terui, Masahiro Yokoyama, Kyoko Ueda, Noriko Nishimura, Yuko Mishima, Sakura Sakajiri, Naoko Tsuyama, Kengo Takeuchi & Kiyohiko Hatake. (2013) Prognostic value of high thymidine kinase activity in patients with previously untreated diffuse large B-cell lymphoma treated by rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone. Leukemia & Lymphoma 54:11, pages 2412-2417.
Read now
Mark Prichard, Thomas Harris, Michael E Williams & John J Densmore. (2009) Treatment strategies for relapsed and refractory aggressive non-Hodgkin's lymphoma. Expert Opinion on Pharmacotherapy 10:6, pages 983-995.
Read now

Articles from other publishers (9)

Yoshikazu Ikoma, Nobuhiko Nakamura, Junichi Kitagawa, Takao Miwa, Eri Takada, Takuro Matsumoto, Yuhei Shibata, Hiroshi Nakamura, Nobuhiro Kanemura, Senji Kasahara, Takeshi Hara, Michio Sawada, Hisashi Tsurumi & Masahito Shimizu. (2023) A phase II study of gemcitabine, carboplatin, dexamethasone, and rituximab in patients with relapsed or refractory non‐Hodgkin lymphoma. Hematological Oncology.
Crossref
Sarah Barton, Eliza A. Hawkes, David Cunningham, Clare Peckitt, Sue Chua, Andrew Wotherspoon, Ayoma Attygalle, Alan Horwich, Mike Potter, Mark Ethell, Claire Dearden, Mary Gleeson & Ian Chau. (2014) Rituximab, Gemcitabine, Cisplatin and Methylprednisolone (R‐ GEM ‐P) is an effective regimen in relapsed diffuse large B‐cell lymphoma . European Journal of Haematology 94:3, pages 219-226.
Crossref
Eliza A. Hawkes, Sarah Barton, David Cunningham, Clare Peckitt, Sue Chua, Andrew Wotherspoon, Alan Horwich, Mike Potter, Mark Ethel, Claire Dearden & Ian Chau. (2013) GEM-P chemotherapy is active in the treatment of relapsed Hodgkin lymphoma. Annals of Hematology 93:5, pages 827-834.
Crossref
Venu K. Thirukonda & Adam M. Petrich. (2012) Treatment of Diffuse Large B-cell Lymphoma. Pathology Case Reviews 17:2, pages 90-97.
Crossref
PAOLO G. GOBBI, LARA VILLANO, DONATELLA POZZOLI & MANUELA BERGONZI. (2010) Role of conventional salvage multiple-drug chemotherapy in relapsed and refractory aggressive non-Hodgkin lymphomas. Oncology Letters 1:4, pages 679-683.
Crossref
Sung Yong Oh, Won Seog Kim, Dae Ho Lee, Seok Jin Kim, Sung Hyun Kim, Baek Yeol Ryoo, Hye Jin Kang, Young Jin Choi, Joo Seop Chung, Hyo Jung Kim & Cheolwon Suh. (2009) Phase II study of Gemcitabine for treatment of patients with advanced stage marginal zone B-cell lymphoma: Consortium for Improving Survival of Lymphoma (CISL) trial. Investigational New Drugs 28:2, pages 171-177.
Crossref
Gaetano Corazzelli, Gaetana Capobianco, Manuela Arcamone, Pier Ferruccio Ballerini, Emilio Iannitto, Filippo Russo, Ferdinando Frigeri, Cristina Becchimanzi, Gianpaolo Marcacci, Annarosaria De Chiara & Antonio Pinto. (2009) Long-term results of gemcitabine plus oxaliplatin with and without rituximab as salvage treatment for transplant-ineligible patients with refractory/relapsing B-cell lymphoma. Cancer Chemotherapy and Pharmacology 64:5, pages 907-916.
Crossref
P G Gobbi, F Valentino, P Lambelet, V Perfetti, G Bergamaschi, M Girino & G R Corazza. (2009) Shortened and intensified MJMA: an effective salvage therapy for relapsed and refractory lymphomas and a strong mobilizer of PBSCs. Bone Marrow Transplantation 44:1, pages 19-25.
Crossref
. (2008) Current Awareness in Hematological Oncology. Hematological Oncology 26:1, pages 46-53.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.